当前位置:首页 - 行情中心 - 恩华药业(002262) - 财务分析 - 现金流量表

恩华药业

(002262)

  

流通市值:193.02亿  总市值:221.23亿
流通股本:8.84亿   总股本:10.13亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,285,003,178.031,500,521,240.716,358,917,423.444,856,768,608.14
  收到的税费返还407,528.33161,981.99655,090.72382,653.19
  收到其他与经营活动有关的现金40,186,548.1115,488,547.6873,984,119.8871,416,256.26
  经营活动现金流入小计3,325,597,254.471,516,171,770.386,433,556,634.044,928,567,517.59
  购买商品、接受劳务支付的现金978,264,642.45371,185,401.931,537,516,201.541,138,791,461.72
  支付给职工以及为职工支付的现金517,287,737.23259,689,706.71,142,008,395.51819,115,801.87
  支付的各项税费389,493,117.75198,435,011.44750,384,346.82560,502,997.54
  支付其他与经营活动有关的现金1,160,143,375.62529,032,021.431,925,257,933.341,499,010,699.51
  经营活动现金流出小计3,045,188,873.051,358,342,141.55,355,166,877.214,017,420,960.64
  经营活动产生的现金流量净额280,408,381.42157,829,628.881,078,389,756.83911,146,556.95
二、投资活动产生的现金流量:
  取得投资收益收到的现金25,148,727.7612,205,819.7446,367,997.138,124,521.18
  处置固定资产、无形资产和其他长期资产收回的现金净额92,862.329,625339,238.24146,482.4
  收到的其他与投资活动有关的现金3,838,000,0001,579,000,0006,817,000,0005,822,000,000
  投资活动现金流入小计3,863,241,590.081,591,215,444.746,863,707,235.345,860,271,003.58
  购建固定资产、无形资产和其他长期资产支付的现金156,909,930.7980,135,996.94437,407,150.19232,632,606.43
  投资支付的现金--25,158,70025,158,700
  取得子公司及其他营业单位支付的现金176,374.4-77,95043,000
  支付其他与投资活动有关的现金3,791,000,0001,716,000,0006,963,000,0005,632,000,000
  投资活动现金流出小计3,948,086,305.191,796,135,996.947,425,643,800.195,889,834,306.43
  投资活动产生的现金流量净额-84,844,715.11-204,920,552.2-561,936,564.85-29,563,302.85
三、筹资活动产生的现金流量:
  取得借款收到的现金90,000,00061,000,00030,000,00040,000,000
  筹资活动现金流入小计90,000,00061,000,00030,000,00040,000,000
  偿还债务支付的现金80,000,00030,000,00015,000,00055,000,000
  分配股利、利润或偿付利息支付的现金406,400,356.82-366,205,270.12367,016,667.36
  支付其他与筹资活动有关的现金16,632,226.698,126,739.7134,892,430.0728,060,993.68
  筹资活动现金流出小计503,032,583.5138,126,739.71416,097,700.19450,077,661.04
  筹资活动产生的现金流量净额-413,032,583.5122,873,260.29-386,097,700.19-410,077,661.04
四、汇率变动对现金及现金等价物的影响4,545,602668,615.1-1,036,094.54222,198.59
五、现金及现金等价物净增加额-212,923,315.2-23,549,047.93129,319,397.25471,727,791.65
  加:期初现金及现金等价物余额1,342,781,677.221,342,781,677.221,213,462,279.971,213,462,279.97
  期末现金及现金等价物余额1,129,858,362.021,319,232,629.291,342,781,677.221,685,190,071.62
补充资料:
  净利润740,305,782.6-1,054,901,758.25-
  资产减值准备39,862,089.94-39,684,627.5-
  固定资产和投资性房地产折旧78,288,500.21-146,009,287.69-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧78,288,500.21-146,009,287.69-
  无形资产摊销18,353,431.78-23,747,209-
  长期待摊费用摊销31,066,881.06-69,117,388.75-
  处置固定资产、无形资产和其他长期资产的损失-102,555.04--165,788.21-
  固定资产报废损失-28,375.45-835,383.26-
  财务费用-3,300,357.57-3,474,946.8-
  投资损失-35,914,691.23--61,159,905.52-
  递延所得税-2,392,566.17--18,620,207.2-
  其中:递延所得税资产减少-2,392,566.17--18,509,186.79-
    递延所得税负债增加---111,020.41-
  存货的减少-122,537,314.87--125,892,732.07-
  经营性应收项目的减少-226,751,780.81--219,396,623.23-
  经营性应付项目的增加-249,940,564.97-135,417,226.32-
  其他-0.62-2,632,565.88-
  现金的期末余额1,129,858,362.02-1,342,781,677.22-
  减:现金的期初余额1,342,781,677.22-1,213,462,279.97-
  现金及现金等价物的净增加额-212,923,315.2-129,319,397.25-
公告日期2026-08-182026-04-182026-04-182025-10-25
审计意见(境内)标准无保留意见
TOP↑